MSP Recovery, Inc.
A struggling U.S. healthcare recovery services provider facing severe profitability challenges and insolvency risks due to massive debt loads and operational cash burn.
A struggling U.S. healthcare recovery services provider facing severe profitability challenges and insolvency risks due to massive debt loads and operational cash burn.
An investor might consider this stock only for extreme distress play strategies if there is a credible turnaround plan involving debt restructuring or asset sales that could unlock value from the $1.90 billion in operating intangibles. If the company successfully restructures its $2.05 billion liability load and normalizes cash flow, any resulting equity stake could theoretically offer outsized returns upon rehabilitation.
The stock is fundamentally unsafe due to reported net losses of -$1.56 billion and a balance sheet where liabilities exceed assets by over $100 million, making recovery highly improbable without external intervention. The massive operating expense burden relative to revenue and the inability to generate positive operating cash flow indicate that the current business model is unsustainable under prevailing market conditions.
MSP Recovery, Inc. (MSPR) operates as a healthcare recovery services provider focused on assisting patients with medical debt resolution and compliance within the United States healthcare ecosystem. The company primarily serves hospitals, physicians, and other healthcare entities through its specialized collection and recovery solutions while navigating significant regulatory landscapes. Despite substantial asset bases including operating intangibles and long-term assets, the firm has reported consistent net losses and a deteriorating financial position characterized by negative shareholders' equity.
Recent financial performance reflects a catastrophic deterioration in profitability, with net income plunging from -$401.9 million in 2022 to -$1.56 billion in 2024, signaling deep structural issues within the operational model. Despite generating gross profits of $18.2 million, the company is overwhelmed by operating expenses exceeding $1.27 billion and interest payments of $420 million, resulting in a massive non-cash loss adjustment. The balance sheet has collapsed into negative shareholders' equity of -$128.4 million while cash reserves have barely increased to $12.3 million, failing to cover the crushing debt burden.
The healthcare recovery services industry is a fragmented sector within the broader U.S. medical landscape, providing essential but often undervalued services for debt resolution and compliance management. Companies in this space operate under strict regulatory oversight and face intense competition from larger national firms that can leverage economies of scale to offer lower-cost solutions to hospital systems.
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| Cost of Revenue | $-23.4M | $-7.7M | $-18.2M |
| Gross Profit | $23.4M | $7.7M | $18.2M |
| Operating Expenses | $354.9M | $567.6M | $1.29B |
| Operating Income | $-331.5M | $-559.9M | $-1.27B |
| G&A | $24.0M | $26.5M | $22.2M |
| Stock-Based Comp | $20.1M | $830.0K | $0 |
| D&A | $424.0K | $263.0K | $277.0K |
| Other OpEx | $330.9M | $541.1M | $1.27B |
| Non-Operating Income | $-70.4M | $-275.3M | $-282.6M |
| Interest Expense | $121.0M | $289.2M | $420.0M |
| Pre-Tax Income | $-401.9M | $-835.1M | $-1.56B |
| Income Tax | $0 | $0 | $0 |
| Continuing Ops | $-401.9M | $-835.1M | $-1.56B |
| Discontinued Ops | $0 | $0 | $0 |
| Net Income | $-401.9M | $-835.1M | $-1.56B |
| Minority Interest | $-394.5M | $-778.8M | $-1.20B |
| Net to Common | $-7.4M | $-56.3M | $-360.5M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Current Assets | $51.4M | $21.9M | $15.5M |
| Accounts Receivable | $6.2M | $217.0K | $295.0K |
| Prepaid Expenses | $27.7M | $8.9M | $1.6M |
| Other Current Assets | $17.5M | $12.8M | $13.5M |
| Long-Term Assets | $3.37B | $3.14B | $1.90B |
| PP&E (Net) | $3.4M | $4.9M | $5.2M |
| Intangibles | $3.36B | $3.13B | $1.90B |
| Operating Leases | — | $342.0K | $227.0K |
| Other LT Assets | $0 | $0 | $0 |
| Total Assets | $3.42B | $3.16B | $1.92B |
| Current Liabilities | $115.7M | $46.5M | $1.27B |
| Accounts Payable | $8.4M | $6.2M | $14.0M |
| Current Leases | — | $109.0K | — |
| Other Current Liab | $107.3M | $40.2M | $1.25B |
| Long-Term Liabilities | $1.11B | $1.69B | $782.2M |
| LT Operating Leases | — | $235.0K | $102.0K |
| Other LT Liab | — | $1.69B | $782.1M |
| Total Liabilities | $1.23B | $1.74B | $2.05B |
| Shareholders' Equity | $2.19B | $1.42B | $-128.4M |
| Paid-In Capital | $136.8M | $357.9M | $546.6M |
| Retained Earnings | $-29.2M | $-85.6M | $-446.1M |
| Total L&E | $3.42B | $3.16B | $1.92B |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net Income (CFO) | $-401.9M | $-835.1M | $-1.56B |
| Non-Cash Adjustments | $289.8M | $814.7M | $1.41B |
| Working Capital Changes | $31.5M | $-19.5M | $134.0M |
| Cash from Operations | $-80.6M | $-40.0M | $-16.1M |
| Capital Expenditures | $3.0M | $1.7M | $525.0K |
| Cash from Investing | $-5.7M | $7.6M | $-2.7M |
| Cash from Financing | $99.7M | $29.0M | $19.5M |
| FX Effect | $0 | $0 | $0 |
| Net Change in Cash | $13.4M | $-3.4M | $695.0K |
| Beginning Cash | $1.7M | $15.1M | $11.6M |
| Ending Cash | $15.1M | $11.6M | $12.3M |
The company's operations are concentrated in medical debt recovery and patient care coordination services, with revenue streams derived from fee-for-service collection models and potentially government or insurance contract reimbursements related to healthcare compliance. Financial data suggests a heavy reliance on non-cash adjustments and significant other operating expenses that outweigh gross profits, indicating a business model under severe strain.
The company faces an existential risk due to a total liabilities position of $2.05 billion against only $1.92 billion in total assets, indicating insolvency and potential liquidation scenarios. Severe cash flow from operations of -$16.1 million combined with massive interest expense obligations creates a high probability of default on debt covenants or bankruptcy filings. The business model is highly vulnerable to regulatory changes in healthcare compliance that could further restrict revenue collection capabilities.
The firm possesses specialized industry knowledge in complex medical debt recovery regulations and established relationships with healthcare providers who require compliant collection services. Its substantial portfolio of operating intangibles and long-term assets suggests historical brand recognition or proprietary technology platforms within the niche recovery market, though these are currently being eroded by financial distress.
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.